Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 200 of 451 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/21/20
End: 08/26/21
Due: 08/26/22
Phase: N/A
Priority: Normal
Start: 09/30/10
End: 02/28/11
Due: 02/28/12
Phase: N/A
Priority: Normal
Start: 09/30/14
End: 06/30/16
Due: 06/30/17
Phase: N/A
Priority: Normal
Start: 07/19/19
End: 03/10/20
Due: 03/10/21
Phase: N/A
Priority: Normal
Start: 09/23/20
End: 06/16/23
Due: 06/16/24
Phase: N/A
Priority: Normal
Start: 11/15/18
End: 08/27/24
Due: 08/27/25
Phase: N/A
Priority: Normal
Start: 06/30/11
End: 11/30/16
Due: 11/30/17
Relugolix in Combination With Radiation Therapy for Treating Patients With High Risk Prostate Cancer
Phase: N/A
Priority: Normal
Start: 11/20/23
End: 10/23/26
Due: 10/23/27
Phase: N/A
Priority: Normal
Start: 02/28/09
End: 07/31/15
Due: 07/31/16
Phase: N/A
Priority: Normal
Start: 11/08/21
End: 02/07/23
Due: 02/07/24
Phase: N/A
Priority: Normal
Start: 01/03/23
End: 10/05/23
Due: 10/05/24
Phase: N/A
Priority: Normal
Start: 10/01/25
End: 12/19/26
Due: 12/19/27
Phase: N/A
Priority: Normal
Start: 09/30/07
End: 05/31/10
Due: 05/31/11
Phase: N/A
Priority: Normal
Start: 05/09/22
End: 08/01/27
Due: 08/01/28
Phase: N/A
Priority: Normal
Start: 07/31/05
End: 02/28/10
Due: 02/28/11
Phase: N/A
Priority: Normal
Start: 03/01/23
End: 07/15/26
Due: 07/15/27
Phase: N/A
Priority: Normal
Start: 11/05/23
End: 10/01/25
Due: 10/01/26
Phase: N/A
Priority: Normal
Start: 07/01/21
End: 08/01/27
Due: 08/01/28
Phase: N/A
Priority: Normal
Start: 03/31/11
End: 06/30/16
Due: 06/30/17
Phase: N/A
Priority: Normal
Start: 06/25/20
End: 05/11/21
Due: 05/11/22
Phase: N/A
Priority: Normal
Start: 01/21/20
End: 11/22/23
Due: 11/22/24
Phase: N/A
Priority: Normal
Start: 03/31/15
End: 05/05/21
Due: 05/05/22
Phase: N/A
Priority: Normal
Start: 04/13/17
End: 05/11/19
Due: 05/11/20
Phase: N/A
Priority: Normal
Start: 09/21/21
End: 05/31/24
Due: 05/31/25
Phase: N/A
Priority: Normal
Start: 06/01/21
End: 05/01/24
Due: 05/01/25